VLDB 2026 Research / reviewers in the wild / expert
Michael Piechotta
dblp:132/3437
· DBLP profile ↗
3ranked-venue papers
2as first author
1since 2021 · last 2024
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3 · 2 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 66% Medical and health informatics · 34% |
Topics — the 5 heaviest of 6, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › biomedical text mining
entity normalization |
0.8 | 1 | 2024 | preon: Fast and accurate entity normalization for drug names and cancer types in precision oncology · Bioinform. 2024 |
Medical and health informatics › precision medicine
precision oncology |
0.8 | 1 | 2024 | preon: Fast and accurate entity normalization for drug names and cancer types in precision oncology · Bioinform. 2024 |
Bioinformatics and computational biology
genomics |
0.2 | 1 | 2013 | ACCUSA2: multi-purpose SNV calling enhanced by probabilistic integration of quality scores · Bioinform. 2013 |
Bioinformatics and computational biology › genomics › computational genomics
SNP detection |
0.2 | 1 | 2013 | ACCUSA2: multi-purpose SNV calling enhanced by probabilistic integration of quality scores · Bioinform. 2013 |
Bioinformatics and computational biology › genomics
variant calling |
0.2 | 1 | 2013 | ACCUSA2: multi-purpose SNV calling enhanced by probabilistic integration of quality scores · Bioinform. 2013 |
Methods — techniques the papers use, named apart from their topics
string matching · 0.8read mapping quality scores · 0.2probabilistic integration of base quality scores · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2024 | preon: Fast and accurate entity normalization for drug names and cancer types in precision oncologyabstractMOTIVATION: In precision oncology (PO), clinicians aim to find the best treatment for any patient based on their molecular characterization. A major bottleneck is the manual annotation and evaluation of individual variants, for which usually a range of knowledge bases are screened. To incorporate and integrate the vast information of different databases, fast and accurate methods for harmonizing databases with different types of information are necessary. An essential step for harmonization in PO includes the normalization of tumor entities as well as therapy options for patients. SUMMARY: preon is a fast and accurate library for the normalization of drug names and cancer types in large-scale data integration. AVAILABILITY AND IMPLEMENTATION: preon is implemented in Python and freely available via the PyPI repository. Source code and the data underlying this article are available in GitHub at https://github.com/ermshaua/preon/. Arik Ermshaus, Michael Piechotta, Gina Rüter, Ulrich Keilholz, Ulf Leser, Manuela Benary |
Bioinform. | 2 |
| 2017 | JACUSA: site-specific identification of RNA editing events from replicate sequencing dataabstractBACKGROUND: RNA editing is a co-transcriptional modification that increases the molecular diversity, alters secondary structure and protein coding sequences by changing the sequence of transcripts. The most common RNA editing modification is the single base substitution (A→I) that is catalyzed by the members of the Adenosine deaminases that act on RNA (ADAR) family. Typically, editing sites are identified as RNA-DNA-differences (RDDs) in a comparison of genome and transcriptome data from next-generation sequencing experiments. However, a method for robust detection of site-specific editing events from replicate RNA-seq data has not been published so far. Even more surprising, condition-specific editing events, which would show up as differences in RNA-RNA comparisons (RRDs) and depend on particular cellular states, are rarely discussed in the literature. RESULTS: We present JACUSA, a versatile one-stop solution to detect single nucleotide variant positions from comparing RNA-DNA and/or RNA-RNA sequencing samples. The performance of JACUSA has been carefully evaluated and compared to other variant callers in an in silico benchmark. JACUSA outperforms other algorithms in terms of the F measure, which combines precision and recall, in all benchmark scenarios. This performance margin is highest for the RNA-RNA comparison scenario. We further validated JACUSA's performance by testing its ability to detect A→I events using sequencing data from a human cell culture experiment and publicly available RNA-seq data from Drosophila melanogaster heads. To this end, we performed whole genome and RNA sequencing of HEK-293 cells on samples with lowered activity of candidate RNA editing enzymes. JACUSA has a higher recall and comparable precision for detecting true editing sites in RDD comparisons of HEK-293 data. Intriguingly, JACUSA captures most A→I events from RRD comparisons of RNA sequencing data derived from Drosophila and HEK-293 data sets. CONCLUSION: Our software JACUSA detects single nucleotide variants by comparing data from next-generation sequencing experiments (RNA-DNA or RNA-RNA). In practice, JACUSA shows higher recall and comparable precision in detecting A→I sites from RNA-DNA comparisons, while showing higher precision and recall in RNA-RNA comparisons. Michael Piechotta, Emanuel Wyler, Uwe Ohler, Markus Landthaler, Christoph Dieterich |
BMC Bioinform. | 1 |
| 2013 | ACCUSA2: multi-purpose SNV calling enhanced by probabilistic integration of quality scoresabstractSUMMARY: Direct comparisons of assembled short-read stacks are one way to identify single-nucleotide variants. Single-nucleotide variant detection is especially challenging across samples with different read depths (e.g. RNA-Seq) and high-background levels (e.g. selection experiments). We present ACCUSA2 to identify variant positions where nucleotide frequency spectra differ between two samples. To this end, ACCUSA2 integrates quality scores for base calling and read mapping into a common framework. Our benchmarks demonstrate that ACCUSA2 is superior to a state-of-the-art SNV caller in situations of diverging read depths and reliably detects subtle differences among sample nucleotide frequency spectra. Additionally, we show that ACCUSA2 is fast and robust against base quality score deviations. AVAILABILITY: ACCUSA2 is available free of charge to academic users and may be obtained from https://bbc.mdc-berlin.de/software. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Michael Piechotta, Christoph Dieterich |
Bioinform. | 1 |